When hospitalised with chronic heart failure, survival could come down to the hospital food
Randomised controlled trial: Subjects are randomly assigned to a test group, which receives the treatment, or a control group, which commonly receives a placebo. In 'blind' trials, participants do not know which group they are in; in ‘double blind’ trials, the experimenters do not know either. Blinding trials helps removes bias.
People: This is a study based on research using people.
Professional nutrition support for patients hospitalised with chronic heart failure could be the difference between survival and death, according to a Swiss study. Of 645 patients hospitalised in Switzerland with chronic heart failure who were at risk of malnutrition, half were given individualised nutritional support, while the other half were given regular hospital food options. After 30 days, about one in 12 patients given nutritional support had died, compared to just under one in seven for those without the support. After 180 days, just over one in four patients who had been given the nutritional support had died, and just under one in three patients without the support had died. The researchers found those most at risk of malnutrition benefitted the most from intervention.
Journal/conference: JACC
Link to research (DOI): 10.1016/j.jacc.2021.03.232
Organisation/s: Kantonsspital Aarau, Switzerland
Attachments:
Note: Not all attachments are visible to the general public
